Lataa...
Selection of first-line systemic therapies for advanced hepatocellular carcinoma: A network meta-analysis of randomized controlled trials
BACKGROUND: The majority of clinical trials of first-line systemic treatments for hepatocellular carcinoma (HCC) used placebo or sorafenib as comparators, and there are limited data providing a cross comparison of treatments in this setting, especially for newly-approved immune checkpoint inhibitor...
Tallennettuna:
| Julkaisussa: | World J Gastroenterol |
|---|---|
| Päätekijät: | , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Baishideng Publishing Group Inc
2021
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8130040/ https://ncbi.nlm.nih.gov/pubmed/34040331 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v27.i19.2415 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|